[HTML][HTML] What is the role of imaging at primary diagnostic work-up in uterine cervical cancer?
IS Haldorsen, N Lura, J Blaakær, D Fischerova… - Current oncology …, 2019 - Springer
Abstract Purpose of Review For uterine cervical cancer, the recently revised International
Federation of Gynecology and Obstetrics (FIGO) staging system (2018) incorporates …
Federation of Gynecology and Obstetrics (FIGO) staging system (2018) incorporates …
[HTML][HTML] The role of squamous cell carcinoma antigen (SCC Ag) in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with …
J Fu, W Wang, Y Wang, C Liu, P Wang - Radiation Oncology, 2019 - Springer
At present, the standard treatment approach for locally advanced cervical cancer is
concurrent chemoradiotherapy (CCRT). An elevated pretreatment squamous cell carcinoma …
concurrent chemoradiotherapy (CCRT). An elevated pretreatment squamous cell carcinoma …
[HTML][HTML] Squamous cell carcinoma antigen: clinical application and research status
H Zhu - Diagnostics, 2022 - mdpi.com
The squamous cell carcinoma antigen (SCCA) is a tumor marker that has gained increasing
attention for its biological functions and significance in normal physiological and …
attention for its biological functions and significance in normal physiological and …
MRI-derived radiomics: methodology and clinical applications in the field of pelvic oncology
U Schick, F Lucia, G Dissaux, D Visvikis… - The British journal of …, 2019 - academic.oup.com
Personalized medicine aims at offering optimized treatment options and improved survival
for cancer patients based on individual variability. The success of precision medicine …
for cancer patients based on individual variability. The success of precision medicine …
[HTML][HTML] Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer
W Chen, S Xiu, X Xie, H Guo, Y Xu, P Bai, X Xia - Radiation Oncology, 2022 - Springer
Objective To investigate the prognostic relevance of specific measurement parameters such
as tumor diameter, tumor volume, tumor volume reduction rate (TVRR), and changes in the …
as tumor diameter, tumor volume, tumor volume reduction rate (TVRR), and changes in the …
Prognostic Value of Volume-Based Metabolic Parameters of 18F-FDG PET/CT in Uterine Cervical Cancer: A Systematic Review and Meta-Analysis
S Han, H Kim, YJ Kim, CH Suh… - American Journal of …, 2018 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this study is to perform a systematic review and meta-analysis
of volume-based 18F-FDG PET/CT parameters regarding the prognostic value of metabolic …
of volume-based 18F-FDG PET/CT parameters regarding the prognostic value of metabolic …
[HTML][HTML] What MRI-based tumor size measurement is best for predicting long-term survival in uterine cervical cancer?
N Lura, KS Wagner-Larsen, D Forsse, J Trovik… - Insights into …, 2022 - Springer
Background Tumor size assessment by MRI is central for staging uterine cervical cancer.
However, the optimal role of MRI-derived tumor measurements for prognostication is still …
However, the optimal role of MRI-derived tumor measurements for prognostication is still …
[HTML][HTML] Interobserver agreement and prognostic impact for MRI–based 2018 FIGO staging parameters in uterine cervical cancer
Objectives To evaluate the interobserver agreement for MRI–based 2018 International
Federation of Gynecology and Obstetrics (FIGO) staging parameters in patients with cervical …
Federation of Gynecology and Obstetrics (FIGO) staging parameters in patients with cervical …
[HTML][HTML] The prognostic value of tumor size, volume and tumor volume reduction rate during concurrent chemoradiotherapy in patients with cervical cancer
C Sun, S Wang, W Ye, RL Wang, M Tan… - Frontiers in …, 2022 - frontiersin.org
Objective The purpose of this study was to investigate the relation between prognostic and
tumour parameters of cervical cancer patients, such as tumour size (TS), tumour volume …
tumour parameters of cervical cancer patients, such as tumour size (TS), tumour volume …
A multi-institutional retrospective analysis of oncologic outcomes for patients with locally advanced cervical cancer undergoing platinum-based adjuvant …
N Wu, X Su, H Song, Y Li, F Gu, X Sun, X Li… - Cancer …, 2021 - journals.sagepub.com
Objective: To evaluated the oncologic outcomes associated with platinum-based adjuvant
chemotherapy following concurrent chemoradiotherapy (CCRT) in the management of …
chemotherapy following concurrent chemoradiotherapy (CCRT) in the management of …